Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 668.70
+31.80 (4.99%)
At close: Sep 4, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 71.07 billion as of September 4, 2026. Its market cap has increased by 324.60% in one year.
Market Cap
71.07B
Enterprise Value
69.79B
Revenue
10.05B
Ranking
n/a
PE Ratio
52.98
Stock Price
668.70
ChartMarket Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 71.07B, an increase of 706,890.37%. That is a compound annual growth rate of 43.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 71.07B | 310.87% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 143.55B |
| Viyash Scientific | 113.72B |
| Procter & Gamble Health | 94.27B |
| Sanofi India | 73.00B |
| Morepen Laboratories | 64.33B |
| FDC Limited | 55.62B |
| Gufic Biosciences | 44.05B |
| Novartis India | 39.87B |